Besides Australia ( n = 3), Iran ( n = 2), New Zealand ( n = 1), Palestine ( n = 1), most studies were from the United States ( n = 4), United Kingdom ( n = 5), and Europe ( n = 5)
Because lower injection frequency can lead to enhanced patient satisfaction and better treatment outcomes, the once-weekly category has emerged as a major force in the market
For glucose control, head-to-head trials have shown that oral semaglutide 14mg produces HbA1c reductions comparable to the injectable form at lower doses, making it a clinically meaningful option for many patients with type 2 diabetes whose primary goal is glucose management with cardiovascular protection
this hypothesis is also given credence by the common finding of GSTP overexpression in tumor cell lines that are not drug resistant
At the same time, this substance has several side effects that you should be aware of and might cause a chain reaction (e.g., diarrhea , worse nutrient absorption nutrient deficiencies)